Andrew M Fry

10PUBLICATIONS
40CO-AUTHORS
Haematological tumoursMolecular targetsComputational physiologyBiologically active moleculesMicrobial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2022
Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer.

Savvas Papageorgiou, Sarah L Pashley, Laura O'Regan

|Jan 24, 2022
Construction of a human hTERT RPE-1 cell line with inducible Cre for editing of endogenous genes.

Naushin L Hindul, Amarjot Jhita, Daiana G Oprea

|Oct 18, 2021
Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation.

Josephina Sampson, Mark W Richards, Jene Choi

|Jan 22, 2021
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase.

Christopher J Matheson, Christopher R Coxon, Richard Bayliss

Pageof 2